• About

Collaborate Through Research, Partner for Progress

Bringing researchers around the world for faster delivery of benefits from science and research.

IRPC Associates

Professor Rodney J. Scott, PhD, PD, FRCPath, FHGSA
Head of the Discipline of Medical Genetics, School of Biomedical Sciences, Faculty of Health, University of Newcastle, Australia.
Phone (02) 4921 4974, Fax (02) 4921 4253
E mail: rodney.scott@newcastle.edu.au

About Prof. Scott:
Prof. Rodney J. Scott, an eminent scientist and an expert in Genetics is presently the Director of Genetics and the Head of the Discipline of Medical Genetics at the University of Newcastle. Prof. Rodney J. Scott obtained his PhD from the University of Western Australia in 1987. Since that time he has been engaged in research directed at understanding the relationship between the genetic basis of disease and environmental exposures that potentially impinge on the ability to maintain genomic integrity. His achievements were recognized by the award of Privat Dozent in Cancer Genetics, by the University of Basel in 1997 and his Fellowship of the Royal College of Pathologists in 2005. In 1997 he took up my appointment with the Hunter Area Pathology Service as Director of Genetics and became the Head of the Discipline of Medical Genetics at the University of Newcastle at the end of 1999. In 1999 he was invited to become a visiting Professor at the Pomeranian Medical University in Poland and in 2005 was appointed as a Fellow in Children's Cancer Genetics Research and has been involved in a national study examining the causes of childhood acute lymphoblastic leukaemia.

Prof. Scott has published extensively in high impact factor internationally peer-reviewed articles with high citation indices (for example Ford D, et al Am J Hum Genet 1998:62: 676-689 cited 911 times according to ISI) and has an extensive publication record in genetic association studies. He often asked to speak at international and national meetings about my findings and to write editorials for international genetics journals.

Prof. Scott currently is an advisor to the NSW Cancer Institute's Familial Bowel Cancer Registry and he is also chair of the Board of Censors for Molecular Genetics, Human Genetics Society of Australasia. As the discipline lead in genetics he teachs in the medical and biomedical science programs and he also an examiner for the Royal College of Pathologists of Australasia and for the Human Genetics Society of Australasia (HGSA). He sits on a number of boards that include the scientific advisory board of the Cancer Institute of New South Wales, the Genetic Services Advisory Committee and the DNA working party of the New South Wales Department of Health, the Cancer Genetics Register of the NSW Cancer Institute (formerly with the NSW Cancer Council), the scientific board of SUPAMAC.

Prof. Scott is co-editor of the Journal Hereditary Cancer in Clinical Practice and a reviewer for Gut, Human Genetics, Human Heredity, Journal of Medical Genetics, European Journal of Cancer, Molecular Pathology, Human Mutation, European Journal of Genetics, Genes Chromosomes and Cancer, Pathology, Clinical Genetics, American Journal of Medical Genetics, Scandinavian Journal of Gastroenterology International Journal of Epidemiology, Oncogene, Biomed Central, Clinical Cancer Research, Cancer Epidemiology Biomarkers and Prevention, International Journal of Cancer and Lancet Oncology.

Prof. Scott reviews grants for the NHMRC, the Canadian Medical Research Council, the Swiss National Foundation, the Cancer Council of Victoria, the Heart Foundation, the Cure Cancer Australia foundation, the Royal Australian college of Physicians, the Georgian National Scientific Foundation and the MRC New Zealand. Prof. Scott has published over 200 articles and presented at more than 120 meetings throughout his career.

University of Newcastle, Australia.
The Hunter Medical Research Institute (HMRI) is a joint venture between Hunter New England Health and the University of Newcastle in partnership with the community.

HMRI was established in 1998 to take advantage of the region's strategic advances in health and medical research and biotechnology including the strengths of its founding institutions, the University of Newcastle and Hunter New England Health. It has grown to become one of the state's leading health and medical research institutes, and the third largest medical research institute in NSW measured by peer reviewed grant income.

HMRI has more than 550 researchers employed by the University of Newcastle, Hunter New England Area Health Service and the Calvary Mater Newcastle Hospital working in seven research programs: Brain & Mental Health, Cancer, Cardiovascular Health, Health Behaviour & Public Health, Information Based Medicine, Pregnancy & Reproduction and Viruses, Infection / Immunity, Vaccines & Asthma (VIVA).

HMRI is a multi-campus institute with researchers spread across several sites. These include the University of Newcastle, John Hunter Hospital, the Royal Newcastle Centre, Calvary Mater Newcastle Hospital, David Maddison Building, James Fletcher Hospital, Wallsend Campus and Hunter Genetics.

The regional strategy of the HMRI Board is to consolidate these seven scattered locations into three neighbouring precincts – the University of Newcastle, Rankin Park Campus and the Calvary Mater Newcastle Hospital.

HMRI provides a focal point for the coordination of research strategy, resources and funding, attracting corporate investment in research and providing central resources for researchers. Importantly, HMRI has also improved training and employment opportunities and health care delivery within the Hunter Region and has attracted leading researchers and health care professionals to the region.

Chapter Highlights

  • Australian Chapter:- Dr Pam McGrath and her team, International Program of Psycho-Social Health Research (IPP-SHR), have worked closely with IRPC on a range of research projects.
  • Australian Chapter:- Hamish Holewa, IPP-SHR has contributed to the development of IRPC's journal, the Austral-Asian Journal of Cancer, a HERDC recognised, peer-reviewed, multi-disciplinary cancer journal.

Latest News

  • Guide for students living with chronic health conditions
    Managing a chronic illness is challenging under the best of circumstances, but add the stresses of college, and things can quickly spin out of control. This guide touches on a number of pertinent points, including how to balance studies with disease management. Read more
  • Quadrant - Project Management Software for Researchers
    Quadrant is proud to be a supporter and collaborator of the Austral-Asian Journal of Cancer and International Research Promotion Council.
    Quadrant is a cloud-based project management and data collection software tool that allows participant-based researchers to work collaboratively and efficiently from a self-managed centralised site. Quadrant addresses the need for secure and ethical online research project management and data storage.
    Read More
  • New Room provides an interactive forum for all the scientists and researchers to convey important information and news.


Dr. Hillary Klonoff-Cohen


Dr. Hillary Klonoff-Cohen presently serves as the Saul J. Morse & Anne B. Morgan Professor in Applied Health Sciences, Associate Director of Community Health, and the Director of the MPH and PhD Programs in Community Health at the University of Illinois at Urbana-Champaign.

Prof. Hiroaki Honda


Dr. Yoichiro Yamamoto –an eminent scientist and an expert in the field ofmedicineand computer science/mathematics especially including Artificial Intelligence (AI) is presently working as a unit leader of Pathology Informatics Unit at RIKEN Center for Advanced Intelligence Project in Japan.

Dr Guillaume Moulis, MD, PhD


Dr Guillaume Moulis, MD, PhD is currently Assistant Professor in Internal Medicine at Toulouse University Hospital, France. He is also researcher in Pharmacoepidemiology at UMR 1027 Inserm-University of Toulouse and at the 1436 clinical investigation center, Toulouse, France. He is born on 23rd September 1983 in Toulouse, France.